Skip to main content

Investigación y educación

Submitted by remote_content on

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

"A Comprehensive Machine Learning Framework for the Exact Prediction of the Age of Onset in Familial and Sporadic Alzheimer's Disease. Diagnostics (Basel)."

May 17, 2021

Leer más

Neurología

"Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas. Biomedica. "

December 1, 2022

Leer más

Neurología

"Radiofrequency Treatment of Iliac and Paravertebral Cluneal Nerves for Low Back Pain. Pain Physician."

October 25, 2022

Leer más